This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Medtronic's Titan Spine Buyout to Boost Spine Surgery Range
by Zacks Equity Research
Medtronic's (MDT) comprehensive biologics portfolio clubbed with Titan Spine's surface-enhanced titanium implants can enhance patient outcomes in spinal procedures.
Medtronic (MDT) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Medtronic (MDT) closed at $97.21, marking a -1.71% move from the previous day.
CMS' Final Verdict on TAVR: A Boon or Bane for MedTech?
by Urmimala Biswas
While the industry bigwigs are keen to welcome the new CMS ruling, companies like Heart Valve Voice US are not lagging to pen their resistance against a revised policy.
Company News For Jun 24, 2019
by Zacks Equity Research
Companies in the news are: CGC, KMX, MDT and RHT
Medtronic (MDT) Up 8.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Near-Term Outlook for Medical Instruments Industry Bleak
by Urmimala Biswas
Complex regulatory hurdles come in the way of any infrastructural or technology growth in the Medical Instruments space.
Medtronic Delivers Favorable Outcome on Guardian Connect
by Zacks Equity Research
Medtronic's (MDT) data indicates that Guardian Connect will enable patients to better understand glucose trends and increase Time in Range.
Medtronic Receives FDA Nod for SelectSite Catheter System
by Zacks Equity Research
The launch of the SelectSite catheter is in line with Medtronic's (MDT) goal to expand its cardiac care portfolio.
The Zacks Analyst Blog Highlights: Medtronic, TJX, Deere, Incyte and Netapp
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Medtronic, TJX, Deere, Incyte and Netapp
Company News For May 24, 2019
by Zacks Equity Research
Companies In The News Are: LB,NTAP,MDT,AVP
Top Stock Reports for Medtronic, TJX Companies & Deere
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Medtronic (MDT), TJX Companies (TJX) and Deere (DE).
Trade Conflict Escalates
by Zacks Equity Research
Trade Conflict Escalates
Futures Down on Trade Woes; Claims & Earnings Look Good
by Mark Vickery
While pre-market futures are down on a continued souring in trade between the U.S. and China, Jobless Claims, Best Buy and Medtronic brought some good news.
Medtronic (MDT) Q4 Earnings Beat, Operating Margin Rises
by Zacks Equity Research
Excluding the Diabetes group, Medtronic (MDT) displays better performances at CER on the back of growth in rest of the business segments and across all geographies.
Medtronic (MDT) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Medtronic (MDT) delivered earnings and revenue surprises of 5.48% and 0.46%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?
Will RTG Again Bolster Medtronic's (MDT) Earnings in Q4?
by Zacks Equity Research
Within Neurovascular, we hope to witness strength across Medtronic's (MDT) stroke franchise with growth in stent retrievers, flow diverters, neuro access and embolic products.
Medtronic (MDT) to Report Q4 Earnings: Will It Top Estimates?
by Zacks Equity Research
We are upbeat about Medtronic's (MDT) successful execution of growth strategies such as therapy innovation, globalization and increase in economic value.
Medtronic (MDT) Launches Telescope Guide Extension Catheter
by Zacks Equity Research
The launch of Telescope marks Medtronic's (MDT) foray into the guide extension catheter market.
Medtronic (MDT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bull of the Day: Penumbra (PEN)
by Kevin Cook
This $4 billion innovator removes blood clots and the deadly shadow of stroke with catheter-based aspiration technologies
Medtronic to Acquire Titan Spine for Spine Portfolio Boost
by Zacks Equity Research
According to Medtronic (MDT), interbody implants material and shape play a vital role in the bone growth process during fusions and presently, titanium interbody devices are rapidly becoming popular.
Medtronic (MDT) Stock Moves -1.13%: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed the most recent trading day at $87.33, moving -1.13% from the previous trading session.
Medtronic's (MDT) EV ICD Pilot Study Results Encourage
by Zacks Equity Research
The study highlights the benefits of traditional, transvenous ICDs offered by the Medtronic's (MDT) EV ICD system.
Medtronic (MDT) Stock Moves -0.98%: What You Should Know
by Zacks Equity Research
In the latest trading session, Medtronic (MDT) closed at $89.27, marking a -0.98% move from the previous day.
Why Medtronic (MDT) Could Beat Earnings Estimates Again
by Zacks Equity Research
Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.